skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 25,236  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2
Material Type:
Article
Add to My Research

Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS‐CoV‐2

Journal of Medical Virology, 2020-06, Vol.92 (6) [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/jmv.25726

Digital Resources/Online E-Resources

2
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Material Type:
Article
Add to My Research

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Cell, 2020-04, Vol.181 (2), p.281-292.e6 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.02.058 ;PMID: 32155444

Digital Resources/Online E-Resources

3
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Material Type:
Article
Add to My Research

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Cell, 2020-09, Vol.182 (5), p.1284-1294.e9 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.07.012 ;PMID: 32730807

Digital Resources/Online E-Resources

4
In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs
Material Type:
Article
Add to My Research

In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs

Journal of Medical Virology, 2020-10 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/jmv.25987

Digital Resources/Online E-Resources

5
SARS-CoV-2 variants, spike mutations and immune escape
Material Type:
Article
Add to My Research

SARS-CoV-2 variants, spike mutations and immune escape

Nature reviews. Microbiology, 2021-07, Vol.19 (7), p.409-424 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1740-1526 ;EISSN: 1740-1534 ;DOI: 10.1038/s41579-021-00573-0 ;PMID: 34075212

Full text available

6
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Material Type:
Article
Add to My Research

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Nature (London), 2022-02, Vol.602 (7898), p.664-670 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Feb 24, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04386-2 ;PMID: 35016195

Full text available

7
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
Material Type:
Article
Add to My Research

An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction

Nature communications, 2020-09, Vol.11 (1), p.4420-4420, Article 4420 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-18174-5 ;PMID: 32887876

Full text available

8
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Material Type:
Article
Add to My Research

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

Nature (London), 2020-12, Vol.588 (7839), p.682-687 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Dec 24-Dec 31, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2852-1 ;PMID: 33045718

Full text available

9
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Material Type:
Article
Add to My Research

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Nature Communications, 2020-03, Vol.11 (1), p.1620-1620, Article 1620 [Peer Reviewed Journal]

This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by/4.0 ;The Author(s) 2020. corrected publication 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020, corrected publication 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-15562-9 ;PMID: 32221306

Digital Resources/Online E-Resources

10
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Material Type:
Article
Add to My Research

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Nature (London), 2021-05, Vol.593 (7857), p.136-141 [Peer Reviewed Journal]

Copyright Nature Publishing Group May 6, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03412-7 ;PMID: 33706364

Full text available

11
Structural impact on SARS-CoV-2 spike protein by D614G substitution
Material Type:
Article
Add to My Research

Structural impact on SARS-CoV-2 spike protein by D614G substitution

Science, 2021-04, Vol.372 (6541) [Peer Reviewed Journal]

2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abf2303

Digital Resources/Online E-Resources

12
SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
Material Type:
Article
Add to My Research

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

Nature communications, 2021-01, Vol.12 (1), p.372-372, Article 372 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-20653-8 ;PMID: 33446655

Full text available

13
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
Material Type:
Article
Add to My Research

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

Cell, 2019-02, Vol.176 (5), p.1026-1039.e15 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;2019. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2018 Elsevier Inc. 2018 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2018.12.028 ;PMID: 30712865

Digital Resources/Online E-Resources

14
Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors
Material Type:
Article
Add to My Research

Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors

Nature structural & molecular biology, 2019-12, Vol.26 (12), p.1151-1157 [Peer Reviewed Journal]

COPYRIGHT 2019 Nature Publishing Group ;COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Dec 2019 ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2019 ;ISSN: 1545-9993 ;EISSN: 1545-9985 ;DOI: 10.1038/s41594-019-0334-7 ;PMID: 31792450

Full text available

15
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Material Type:
Article
Add to My Research

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Cell, 2020-09, Vol.182 (5), p.1295-1310.e20 [Peer Reviewed Journal]

2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 The Author(s) 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.08.012 ;PMID: 32841599

Digital Resources/Online E-Resources

16
Evolutionary history, potential intermediate animal host, and cross‐species analyses of SARS‐CoV‐2
Material Type:
Article
Add to My Research

Evolutionary history, potential intermediate animal host, and cross‐species analyses of SARS‐CoV‐2

Journal of Medical Virology, 2020-06, Vol.92 (6) [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/jmv.25731

Digital Resources/Online E-Resources

17
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Material Type:
Article
Add to My Research

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Molecular Cell, 2020-05, Vol.78 (4), p.779-784.e5 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 1097-2765 ;EISSN: 1097-4164 ;DOI: 10.1016/j.molcel.2020.04.022 ;PMID: 32362314

Digital Resources/Online E-Resources

18
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
Material Type:
Article
Add to My Research

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Cell Host & Microbe, 2021-01, Vol.29 (1), p.44-57.e9 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 The Authors 2020 ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2020.11.007 ;PMID: 33259788

Digital Resources/Online E-Resources

19
Antibody evasion by the P.1 strain of SARS-CoV-2
Material Type:
Article
Add to My Research

Antibody evasion by the P.1 strain of SARS-CoV-2

Cell, 2021-05, Vol.184 (11), p.2939-2954.e9 [Peer Reviewed Journal]

2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.03.055 ;PMID: 33852911

Full text available

20
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Material Type:
Article
Add to My Research

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Nature (London), 2022-02, Vol.602 (7898), p.676-681 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Feb 24, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04388-0 ;PMID: 35016198

Full text available

Results 1 - 20 of 25,236  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (16,277)

Refine My Results

Creation Date 

From To
  1. Before 1957  (128)
  2. 1957 To 1973  (225)
  3. 1974 To 1990  (735)
  4. 1991 To 2008  (5,271)
  5. After 2008  (18,519)
  6. More options open sub menu

Subject 

  1. Science & Technology  (13,995)
  2. Life Sciences & Biomedicine  (10,816)
  3. Humans  (6,329)
  4. Covid-19  (6,154)
  5. Severe Acute Respiratory Syndrome Coronavirus 2  (5,935)
  6. Spike Protein  (5,173)
  7. Sars-Cov-2  (4,813)
  8. Coronaviruses  (4,806)
  9. Animals  (4,335)
  10. Proteins  (3,911)
  11. Lee, Spike  (3,652)
  12. Spikes  (3,462)
  13. Neurosciences & Neurology  (2,775)
  14. Pandemics  (2,677)
  15. Antibodies  (2,578)
  16. Neurosciences  (2,518)
  17. Vaccines  (2,464)
  18. Viruses  (2,428)
  19. Infections  (2,190)
  20. Mutation  (2,079)
  21. More options open sub menu

Language 

  1. English  (24,682)
  2. Japanese  (2,565)
  3. Swedish  (146)
  4. German  (112)
  5. Portuguese  (75)
  6. Spanish  (71)
  7. French  (62)
  8. Chinese  (51)
  9. Norwegian  (46)
  10. Czech  (29)
  11. Russian  (29)
  12. Polish  (28)
  13. Persian  (22)
  14. Slovak  (18)
  15. Arabic  (15)
  16. Korean  (7)
  17. Italian  (5)
  18. Turkish  (5)
  19. Romanian  (5)
  20. Danish  (5)
  21. More options open sub menu

Searching Remote Databases, Please Wait